(PR-inside.com) NEW YORK, NY / ACCESS Newswire / April 13, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/actinium-lawsuit-submission-form?prid=142726&wire=1 or contact Joseph E. Levi, Esq. via ema